Vaccination of the immunocompromised host;Impfungen bei immunsupprimierten erwachsenen mit hämato-onkologischer erkrankung

Wiener Medizinische Wochenschrift

Volumn 154, Issue 9-10, 2004, Pages 218-225

  Ullmann, Andrew J ^a   Karthaus, Meinolf ^b   Cornely, Oliver A ^c  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b EVANGELISCHES KRANKENHAUS   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Diphtheria; Immunization; Immunosuppression; Influenza; Live attenuated vaccines; Measles; Mumps; Polio; Rubella; Tetanus; Varicella

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; LIVE VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE;

ANTIBODY RESPONSE; B LYMPHOCYTE; CANCER; CONTROLLED STUDY; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; INFLUENZA VACCINATION; REVIEW; TETANUS PROPHYLAXIS; VACCINATION;

EVIDENCE-BASED MEDICINE; HUMANS; IMMUNE TOLERANCE; LEUKEMIA; LYMPHOMA; OPPORTUNISTIC INFECTIONS; PALLIATIVE CARE; RISK FACTORS; STEM CELL TRANSPLANTATION; VACCINATION;

EID: 3242880800     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-004-0068-x     Document Type: Review

References (77)

1. Smith JM, Nemeth TL, McDonald RA (2003) Current immunosuppressive agents: efficacy, side effects, and utilization. Pediatr Clin North Am 50(6): 1283-1300
2. Golaz A, Hardy IR, Strebel P, Bisgard KM, Vitek C, Popovic T et al (2000) Epidemic diphtheria in the Newly Independent States of the Former Soviet Union: implications for diphtheria control in the United States. J Infect Dis 181 [Suppl 1]: 237-243
3. Vitek CR, Bogatyreva EY, Wharton M (2000) Diphtheria surveillance and control in the Former Soviet Union and the Newly Independent States. J Infect Dis 181 [Suppl 1]: 23-26
4. Reinert RR, Al Lahham A, Lemperle M, Tenholte C, Briefs C, Haupts S et al (2002) Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J Antimicrob Chemother 49(1): 61-68
5. Reinert RR, Lutticken R, Bryskier A, Al Lahham A (2003) Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob Agents Chemother 47(2): 489-493
6. Marchese A, Schito GC (2000) Resistance patterns of lower respiratory tract pathogens in Europe. Int J Antimicrob Agents 16 [Suppl 1]: 25-29
7. Schito GC, Georgopoulos A, Prieto J (2002) Antibacterial activity of oral antibiotics against community-acquired respiratory pathogens from three European countries. J Antimicrob Chemother 50 [Suppl]: 7-11
8. Baker PJ (1992) T cell regulation of the antibody response to bacterial polysaccharide antigens: an examination of some general characteristics and their implications. J Infect Dis 165 [Suppl 1]: 44-48
9. Mond JJ, Lees A, Snapper CM (1995) T cell-independent antigens type 2. Annu Rev Immunol 13: 655-692
10. Heidelberger M, Dilapi MM, Siegel M, Walter AW (1950) Persistence of antibodies in human subjects injected with pneumococcal polysaccharides. J Immunol 65(5): 535-541
11. Robbins JB, Schneerson R, Szu SC (1995) Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J Infect Dis 171(6): 1387-1398
12. Robbins JB, Schneerson R, Glode MP, Vann W, Schiffer MS, Liu TY et al (1975) Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria. J Allergy Clin Immunol 56(2): 141-151
13. Chou MY, Brown AE, Blevins A, Armstrong D (1983) Severe pneumococcal infection in patients with neoplastic disease. Cancer 51(8): 1546-1550
14. Schmid GP, Smith RP, Baltch AL, Hall CA, Schiffman G (1981) Antibody response to pneumococcal vaccine in patients with multiple myeloma. J Infect Dis 143(4): 590-597
15. Lazarus HM, Lederman M, Lubin A, Herzig RH, Schiffman G, Jones P et al (1980) Pneumococcal vaccination: the response of patients with multiple myeloma. Am J Med 69(3): 419-423
16. Ammann AJ, Schiffman G, Addiego JE, Wara WM, Wara DW (1981) Immunization of immunosuppressed patients with pneumococcal polysaccharide vaccine. Rev Infect Dis 3 [Suppl]: 160-167
17. Frederiksen B, Specht L, Henrichsen J, Pedersen FK, Pedersen-Bjergaard J (1989) Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease. Eur J Haematol 43(1): 45-49
18. Siber GR, Gorham C, Martin P, Corkery JC, Schiffman G (1986) Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease. Ann Intern Med 104(4): 467-475
19. Siber GR, Weitzman SA, Aisenberg AC (1981) Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens. Rev Infect Dis 3 [Suppl]: 144-159
20. Siber GR, Schur PH, Aisenberg AC, Weitzman SA, Schiffman G (1980) Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med 303(4): 178-182
21. Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, Mutton K et al (2000) Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 82(7): 1261-1265
22. Ambrosino DM, Molrine DC (1993) Critical appraisal of immunization strategies for prevention of infection in the compromised host. Hematol Oncol Clin North Am 7(5): 1027-1050
23. Guinan EC, Molrine DC, Antin JH, Lee MC, Weinstein HJ, Sallan SE et al (1994) Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 57(5): 677-684
24. Hammarstrom V, Pauksen K, Azinge J, Oberg G, Ljungman P (1993) Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction. Support Care Cancer 1(4): 195-199
25. Lortan JE, Vellodi A, Jurges ES, Hugh-Jones K (1992) Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation. Clin Exp Immunol 88(3): 512-519
26. Winston DJ, Ho WG, Schiffman G, Champlin RE, Feig SA, Gale RP (1983) Pneumococcal vaccination of recipients of bone marrow transplants. Arch Intern Med 143(9): 1735-1737
27. Dilworth JA, Mandell GL (1975) Infections in patients with cancer. Semin Oncol 2(4): 349-359
28. Powers DC (1994) Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine. J Med Virol 43(1): 57-61
29. Virelizier JL (1975) Host defences against influenza virus: the role of anti-hemagglutinin antibody. J Immunol 115(2): 434-439
30. Bender BS, Small PA Jr (1992) Influenza: pathogenesis and host defence. Semin Respir Infect 7(1): 38-45
31. Rapezzi D, Sticchi L, Racchi O, Mangerini R, Ferraris AM, Gaetani GF (2003) Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma. Eur J Haematol 70(4): 225-230
32. Nordoy T, Aaberge IS, Husebekk A, Samdal HH, Steinert S, Melby H et al (2002) Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae. Med Oncol 19(2): 71-78
33. Nordoy T, Husebekk A, Aaberge IS, Jenum PA, Samdal HH, Flugsrud LB et al (2001) Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant 28(7): 681-687
34. van der Velden AM, Mulder AH, Hartkamp A, Diepersloot RJ, Velzen-Blad H, Biesma DH (2001) Influenza virus vaccination and booster in B-cell chronic lymphocytic leukaemia patients. Eur J Intern Med 12(5): 420-424
35. Lo W, Whimbey E, Elting L, Couch R, Cabanillas F, Bodey G (1993) Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur J Clin Microbiol Infect Dis 12(10): 778-782
36. Shildt RA, Boyd JF, McCracken JD, Schiffman G, Giolma JP (1983) Antibody response to pneumococcal vaccine in patients with solid tumors and lymphomas. Med Pediatr Oncol 11(5): 305-309
37. Shildt RA, Luedke DW, Kasai G, El Beheri S, Laham MN (1979) Antibody response to influenza immunization in adult patients with malignant disease. Cancer 44(5): 1629-1635
38. Shildt RA, Rubin RR, Schiffman G, Giolma P (1981) Polyvalent pneumococcal immunization of patients with plasma cell dyscrasias. Cancer 48(6): 1377-1380
39. Schafer AI, Churchill WH, Ames P, Weinstein L (1979) The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine. Cancer 43(1): 25-30
40. Stiver HG, Weinerman BH (1978) Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients. Can Med Assoc J 119(7): 733-735, 738
41. Ortbals DW, Liebhaber H, Presant CA, Van AA, III, Lee JY (1977) Influenza immunization of adult patients with malignant diseases. Ann Intern Med 87(5): 552-557
42. Feery BJ, Matthews RN, Evered MG, Gallichio HA (1979) Antibody responses to influenza virus vaccine in patients with acute lymphocytic leukaemia. Aust Paediatr J 15(3): 177-180
43. Feery BJ, Sullivan JR, Hurley TH, Evered MG (1977) Immunization with influenza vaccine in patients with haematological malignant disease. Med J Aust 1(9): 292-294
44. Gross PA, Gould AL, Brown AE (1985) Effect of cancer chemotherapy on the immune response to influenza virus vaccine: review of published studies. Rev Infect Dis 7(5): 613-618
45. Hamarstrom V, Pauksen K, Svensson H, Oberg G, Paul C, Ljungman P (1998) Tetanus immunity in patients with hematological malignancies. Support Care Cancer 6(5): 469-472
46. Hammarstrom V, Pauksen K, Bjorkstrand B, Simonsson B, Oberg G, Ljungman P (1998) Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients. Bone Marrow Transplant 22(1): 67-71
47. Ullmann AJ, Burchardt CA, Lotz J, Kolbe K, Huber C (2004) Tetanus and Diphtheria Antibody Titers after Allogeneic Hematopoietic Stem Cell Transplantion (HSCT). 43rd ICAAC Abstracts, Am Soc Microbiol, September 2003, pp 286
48. Lossos IS, Breuer R, Or R, Strauss N, Elishoov H, Naparstek E et al (1995) Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 60(7): 672-678
49. Feldman S, Gigliotti F, Shenep JL, Roberson PK, Lott L (1990) Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine. J Infect Dis 161(5): 926-931
50. Desaymard C, Feldmann M (1975) Lack of requirement for cell cooperation in the antibody response to DNP conjugated to levan. Cell Immunol 16(1): 106-114
51. Molrine DC, George S, Tarbell N, Mauch P, Diller L, Neuberg D et al (1995) Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease. Ann Intern Med 123(11): 828-834
52. Ambrosino DM, Lee MY, Chen D, Shamberger RC (1992) Response to Haemophilus influenzae type B conjugate vaccine in children undergoing splenectomy. J Pediatr Surg 27(8): 1045-1047
53. Ljungman P, Cordonnier C, de Bock R, Einsele H, Engelhard D, Grundy J et al (1995) Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 15(3): 455-460
54. Pirofski LA, Casadevall A (1998) Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev 11(1): 1-26
55. Ruben FL, Hankins WA, Zeigler Z, Norden CW, Harrison A, Winkelstein A et al (1984) Antibody responses to meningococcal polysaccharide vaccine in adults without a spleen. Am J Med 76(1): 115-121
56. Holmes SJ (1996) Review of recommendations of the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, on varicella vaccine. J Infect Dis 174 [Suppl 3]: 342-344
57. Ljungman P, Duraj V, Magnius L (1991) Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant 7(2): 89-93
58. Engelhard D, Handsher R, Naparstek E, Hardan I, Strauss N, Aker M et al (1991) immune response to polio vaccination in bone marrow transplant recipients. Bone Marrow Transplant 8(4): 295-300
59. Parkkali T, Ruutu T, Stenvik M, Kuronen T, Kayhty H, Hovi T et al (1996) Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. APMIS 104(5): 383-388
60. Bannon MJ (1989) Measles giant cell pneumonia in children with malignant disease: a plea for immunisation. Ir Med J 82(3): 129-130
61. Kaplan LJ, Daum RS, Smaron M, McCarthy CA (1992) Severe measles in immunocompromised patients. JAMA 267(9): 1237-1241
62. Pauksen K, Duraj V, Ljungman P, Sjolin J, Oberg G, Lonnerholm G et al (1992) Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 9(6): 427-432
63. Ljungman P, Fridell E, Lonnqvist B, Bolme P, Bottiger M, Gahrton G et al (1989) Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 159(4): 610-615
64. O'Shea S, Best JM, Banatvala JE (1983) Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis 148(4): 639-647
65. Balfour HH, Jr., Groth KE, Edelman CK, Amren DP, Best JM, Banatvala JE (1981) Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet 1(8229): 1078-1080
66. Lutkes P, Witzke O, Philipp T, Schmitt HJ, Heemann U (2000) Vaccinations and medical recommendations for patients traveling after organ transplantation. Dtsch Med Wochenschr 125(34-35): 1011-1016
67. Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K et al (2002) Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 347(1): 26-34
68. Huang W, Hussey M, Michel F (1999) Transmission of varicella to a gravida via close contacts immunized with varicella-zoster vaccine. A case report. J Reprod Med 44(10): 905-907
69. Brunell PA, Argaw T (2000) Chickenpox attributable to a vaccine virus contracted from a vaccinee with zoster. Pediatrics 106(2): E28
70. Diaz PS, Au D, Smith S, Amylon M, Link M, Smith S et al (1991) Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings. Pediatrics 87(2): 166-170
71. Heininger U (2001) Pertussis: an old disease that is still with us. Curr Opin Infect Dis 14(3): 329-335
72. Cherry JD, Gornbein J, Heininger U, Stehr K (1998) A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16(20): 1901-1906
73. Robbins JB, Schneerson R, Bryla DA, Trollfors B, Taranger J, Lagergard T (1998) Immunity to pertussis. Not all virulence factors are protective antigens. Adv Exp Med Biol 452: 207-218
74. Trollfors B, Lagergard T, Taranger J, Bergfors E, Schneerson R, Robbins JB (2001) Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis. Clin Diagn Lab Immunol 8(5): 1015-1017
75. Trollfors B, Taranger J, Lagergard T, Sundh V, Bryla DA, Schneerson R et al (1999) Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. Clin Infect Dis 28(3): 552-559
76. Olin P, Hallander HO, Gustafsson L, Reizenstein E, Storsaeter J (2001) How to make sense of pertussis immunogenicity data. Clin Infect Dis 33 [Suppl 4]: 288-291
77. Heininger U, Cherry JD, Stehr K (2004) Serologic response and antibody-titer decay in adults with pertussis. Clin Infect Dis 38(4): 591-594